Lamivudine/raltegravir
Lamivudine/raltegravir is a medication used in the treatment of HIV/AIDS. It is a combination of two antiretroviral drugs, lamivudine and raltegravir, which work together to prevent the virus from replicating in the body.
Composition[edit]
The medication is composed of two active ingredients: lamivudine and raltegravir. Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI), which works by blocking the action of an enzyme called reverse transcriptase, which the virus uses to replicate itself. Raltegravir is an integrase inhibitor, which works by blocking another enzyme that the virus uses to insert its genetic material into the cells it infects.
Uses[edit]
Lamivudine/raltegravir is used in the treatment of HIV/AIDS. It is typically used in combination with other antiretroviral drugs as part of a regimen known as antiretroviral therapy (ART). This therapy is designed to reduce the amount of virus in the body, slow the progression of the disease, and improve the quality of life of people living with HIV/AIDS.
Side Effects[edit]
Like all medications, lamivudine/raltegravir can cause side effects. These may include nausea, diarrhea, and headache. In rare cases, it can cause more serious side effects, such as liver problems or a severe skin reaction. Patients should contact their healthcare provider if they experience any unusual or severe side effects.
Interactions[edit]
Lamivudine/raltegravir can interact with other medications, which can affect how it works or increase the risk of side effects. It is important for patients to tell their healthcare provider about all the medications they are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
Precautions[edit]
Before starting treatment with lamivudine/raltegravir, patients should discuss their medical history with their healthcare provider. This includes any history of liver disease, kidney disease, or other medical conditions. Patients should also inform their healthcare provider if they are pregnant, planning to become pregnant, or breastfeeding.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
